[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368640-105":59,"doc-detail-368640-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","caffeine-as-a-modulator-in-oncology-mechanisms-of-action-and-potential-for-adjuvant-therapy","Caffeine as a Modulator in Oncology - Mechanisms of Action and Potential for Adjuvant Therapy","","Caffeine, widely consumed worldwide, is increasingly recognized for potential anticancer activity beyond its established neurological and metabolic effects. The review explains caffeine’s anti-tumor actions through pathway modulation, including phosphodiesterase inhibition, antagonism of adenosine A2A receptors, and interference with DNA damage response signaling via ATR–Chk1. These mechanisms can promote apoptosis, reduce proliferation, and limit metastatic spread, with evidence from in vitro and in vivo studies indicating synergy with chemotherapy and radiation. Epidemiological findings suggest an inverse link between habitual caffeine intake and several cancers, especially liver and colorectal cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/caffeine-as-a-modulator-in-oncology-mechanisms-of-action-and-potential-for-adjuvant-therapy/368640/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/caffeine-as-a-modulator-in-oncology-mechanisms-of-action-and-potential-for-adjuvant-therapy/368640.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What anticancer mechanisms are attributed to caffeine in this review?","Question",{"text":112,"@type":113},"Caffeine is described as inhibiting phosphodiesterases, antagonizing adenosine A2A receptors, and disrupting DNA damage response signaling through the ATR–Chk1 pathway. These effects are linked to apoptosis induction and reduced proliferation and metastatic spread.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does caffeine potentially interact with chemotherapy and radiation therapy?",{"text":117,"@type":113},"In vitro and in vivo studies cited in the review suggest caffeine can enhance the cytotoxic effects of chemotherapeutic agents and radiation therapy, indicating a possible synergistic role in conventional treatments.",{"name":119,"@type":110,"acceptedAnswer":120},"What epidemiological pattern is reported for caffeine consumption and cancer incidence?",{"text":121,"@type":113},"Epidemiological data summarized in the review supports an inverse association between habitual caffeine consumption and the incidence of several cancers. The most consistent evidence is reported for liver and colorectal cancer, with repeated observations related to inflammation and cell proliferation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368640,1790219449,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Review  \nCaffeine as a Modulator in Oncology: Mechanisms of Action and Potential for Adjuvant Therapy  \nNina Rembiałkowska 1, *,†, Alina Demiy 2,†,‡, Alicja Da˛browska 3,‡, Jakub Mastalerz 3,‡ and Wojciech Szlasa 1,4  \nAcademic Editors: Matteo Bordiga and Baojun Xu  \nReceived: 18 May 2025  \nRevised: 23 June 2025  \nAccepted: 26 June 2025  \nPublished: 28 June 2025  \nCitation: Rembiałkowska, N.; Demiy, A.; Da˛browska, A.; Mastalerz, J.; Szlasa, W. Caffeine as a Modulator in Oncology: Mechanisms of Action and Potential for Adjuvant Therapy. Int. J. Mol. Sci. 2025, 26, 6252. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26136252](doi.org/10.3390/ijms26136252)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland; [wojciech.szlasa@umw.edu.pl](wojciech.szlasa@umw.edu.pl)  \n[2](2 Faculty of Pharmacy)[ Faculty of Pharmacy](2 Faculty of Pharmacy), [Wroclaw Medical University](Wroclaw Medical University), [50-556 Wroclaw](50-556 Wroclaw), [Poland](Poland)  \n[3](3 Faculty of Medicine)[ Faculty of Medicine](3 Faculty of Medicine), [Wroclaw Medical University](Wroclaw Medical University), [Pasteura 1](Pasteura 1), [50-367 Wroclaw](50-367 Wroclaw), [Poland](Poland); [jakub.mastalerz@student.umw.edu.pl](jakub.mastalerz@student.umw.edu.pl) (J.M.)  \n4 Lower Silesia Centre for Oncology, Pulmonology and Hematology in Wroclaw, 53-439 Wroclaw, Poland  \n* [Correspondence: nina.rembialkowska@umw.edu.pl](Correspondence: nina.rembialkowska@umw.edu.pl)  \n† These authors contributed equally to this work and share first authorship.  \n‡ The Students’ Research Group, SKN No. 148, Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.  \nAbstract  \nCaffeine, one of the most widely consumed bioactive compounds worldwide, is gaining recognition for its potential anticancer properties beyond its well-known neurological and metabolic effects. Mechanistically, caffeine exerts anti-tumor activity by modulating key cellular pathways involved in carcinogenesis, including the inhibition of phosphodiesterases, antagonism of adenosine A2A receptors, and disruption of the DNA damage response through ATR-Chk1 pathway inhibition. These actions collectively promote apoptosis, suppress tumor cell proliferation, and impair metastatic spread. In vitro and in vivo studies have demonstrated that caffeine can enhance the cytotoxic effects of chemotherapeutic agents and radiation therapy, suggesting a synergistic role in conventional cancer treatments. Epidemiological data further supports an inverse association between habitual caffeine consumption and the incidence of several cancers, notably liver, colorectal, breast, and prostate cancers. Among these, the most consistent experimental and clinical evidence exists for liver and colorectal cancer, where caffeine’s modulatory effects on inflammation and cell proliferation have been repeatedly observed. Additionally, caffeine’s anti-oxidant and anti-inflammatory properties may contribute to a microenvironment less conducive to tumor initiation and progression. While promising, the anticancer effects of caffeine are influenced by factors such as dosage, individual genetic variability, and cancer type, underscoring the need for further clinical investigation. This review explores the emerging role of caffeine as a potential chemopreventive and adjuvant therapeutic agent in oncology.  \nKeywords: caffeine; neuroprotection and neurodegenerative; adjuvant therapy; cognitive effects; fatigue management  \n1. Introduction  \nCaf","cbCainjU9qAhPU29","https://ap.wps.com/l/cbCainjU9qAhPU29","pdf",606564,24,"English","# Introduction\n## Caffeine sources and biological effects\n## Dual antioxidant/pro-oxidant roles in cancer biology\n# Mechanisms Relevant to Oncology\n## Phosphodiesterase inhibition\n## Adenosine A2A receptor antagonism\n## DNA damage response disruption (ATR–Chk1)\n# Synergy With Conventional Cancer Treatments\n## Enhancement of chemotherapy cytotoxicity\n## Interaction with radiation therapy\n# Epidemiological and Clinical Evidence\n## Associations with cancer incidence\n## Stronger evidence for liver and colorectal cancers\n# Factors Modulating Outcomes\n## Dosage and individual genetic variability\n## Cancer type dependence\n# Conclusion and Future Directions\n## Need for further clinical investigation","[{\"question\":\"What anticancer mechanisms are attributed to caffeine in this review?\",\"answer\":\"Caffeine is described as inhibiting phosphodiesterases, antagonizing adenosine A2A receptors, and disrupting DNA damage response signaling through the ATR–Chk1 pathway. These effects are linked to apoptosis induction and reduced proliferation and metastatic spread.\"},{\"question\":\"How does caffeine potentially interact with chemotherapy and radiation therapy?\",\"answer\":\"In vitro and in vivo studies cited in the review suggest caffeine can enhance the cytotoxic effects of chemotherapeutic agents and radiation therapy, indicating a possible synergistic role in conventional treatments.\"},{\"question\":\"What epidemiological pattern is reported for caffeine consumption and cancer incidence?\",\"answer\":\"Epidemiological data summarized in the review supports an inverse association between habitual caffeine consumption and the incidence of several cancers. The most consistent evidence is reported for liver and colorectal cancer, with repeated observations related to inflammation and cell proliferation.\"}]","Caffeine as a Modulator in Oncology - Mechanisms of Action and Potential for Adjuvant Therapy | PDF",1790177819,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bf01cf9cc0a7b70e554c1ea964fceec.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36307548356ff6dd3d45158605365d36.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/024b43999fc40e169a278632ff2744e7.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5820d626c892f559bc05854d8628fa54.webp",980,1385]